Craig Hallum Forecasts Strong Price Appreciation for KORU Medical Systems (NASDAQ:KRMD) Stock

KORU Medical Systems (NASDAQ:KRMD) had its price target increased by Craig Hallum from $5.00 to $6.00 in a report released on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Craig Hallum’s price objective points to a potential upside of 46.70% from the company’s current price.

Other analysts also recently issued reports about the stock. Canaccord Genuity Group lifted their price objective on shares of KORU Medical Systems from $3.00 to $4.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Piper Sandler boosted their price target on shares of KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a research report on Thursday, November 14th. Finally, Lake Street Capital raised their price objective on KORU Medical Systems from $4.00 to $5.00 and gave the company a “buy” rating in a report on Tuesday, January 14th. Four analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $4.50.

KORU Medical Systems Stock Up 2.3 %

Shares of KORU Medical Systems stock opened at $4.09 on Friday. The firm has a market cap of $187.49 million, a PE ratio of -16.36 and a beta of 0.45. The business’s 50 day simple moving average is $3.82 and its 200 day simple moving average is $2.97. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.37 and a current ratio of 2.99. KORU Medical Systems has a 52-week low of $1.98 and a 52-week high of $4.60.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Meros Investment Management LP lifted its stake in KORU Medical Systems by 20.7% in the 2nd quarter. Meros Investment Management LP now owns 804,380 shares of the company’s stock valued at $2,132,000 after purchasing an additional 137,918 shares during the last quarter. Empire Financial Management Company LLC acquired a new stake in shares of KORU Medical Systems in the third quarter valued at approximately $259,000. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of KORU Medical Systems during the 2nd quarter worth approximately $107,000. Geode Capital Management LLC boosted its stake in shares of KORU Medical Systems by 6.5% during the 3rd quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock worth $1,262,000 after acquiring an additional 28,323 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. increased its holdings in shares of KORU Medical Systems by 77.7% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock worth $168,000 after acquiring an additional 26,860 shares during the last quarter. Institutional investors own 58.60% of the company’s stock.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.